Project Grant R21AI196949
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $240,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 5, 2025, with completion targeted for August 31, 2027. The grant funds investigative research into bile resistance mechanisms in Pseudomonas aeruginosa (PA), a leading cause of healthcare-associated infections resulting...
- Federal Project Grant Award Summary Northwestern University's Sponsored Research Division received a $200,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 4, 2025, with a completion date of August 31, 2027. The award funds research to identify and validate microRNA (miRNA) molecules that regulate neutrophil transendothelial migration in gut inflammation, with the...
- Federal Grant Award Summary The University of Illinois received a $582,350 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 8, 2025, with completion targeted for June 30, 2030. The grant funds investigator-initiated research to identify microbiota-mediated colonization resistance mechanisms against Acinetobacter baumannii, a multidrug-resistant pathogen that poses...
- Federal Grant Award Summary Princeton University's Office of Research and Project Administration received a $451,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 23, 2025, with completion targeted for June 30, 2027. The research initiative employs chemical synthetic lethality methodology to identify novel antimicrobial targets in gram-negative bacterial...
- Federal Grant Award Summary Northwestern University received a $106,922 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective March 9, 2026 through September 8, 2028. The award supports biomedical research investigating the metabolic regulation of regulatory T cells (Tregs) through fatty acid metabolism during viral pneumonia. The research focuses on understanding how Tregs...
- Federal Project Grant Award Summary The University of Illinois received a $585,539 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 4, 2025, through August 31, 2030. This research project investigates Acinetobacter baumannii carbon metabolism during intermicrobial competition in the gastrointestinal tract, with the goal of developing prevention strategies for...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Illinois a Project Grant of $736,822 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for a five-year research initiative spanning February 1, 2026 through January 31, 2031. This award supports investigator-initiated research examining bacterial lipases produced by Staphylococcus aureus and their mechanisms of adaptation to the host lipid environment...
- Federal Grant Award Summary Princeton University, through its Office of Research and Project Administration, received a $410,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective April 15, 2025, with an ultimate completion date of March 31, 2027. The award supports research examining the influence of chromosome copy number on Pseudomonas aeruginosa persisters to...
- Federal Project Grant Award Summary Northwestern University's Sponsored Research Division received a $106,922 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 26, 2026, with a completion date of October 31, 2028. The award supports biomedical research investigating the mechanisms of food allergen absorption and anaphylaxis, with emphasis on identifying the role...
- Federal Grant Award Summary The University of Illinois received a $1.14 million Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025, through July 31, 2030. This award funds research to identify physicochemical traits that enable small molecule compounds to evade efflux pump mechanisms in gram-negative bacteria. The research will measure accumulation of...
Northwestern University's Sponsored Research Division received a $431,784 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 19, 2026, through January 31, 2028. The award funds research to investigate Pseudomonas aeruginosa (PA) carriage in the gastrointestinal tract, a critical public health concern given PA's role in over 75,000 nosocomial infections annually in the United States. The research leverages a previously established and characterized mouse model of PA gastrointestinal carriage to identify carriage-facilitating factors produced by PA bacteria that enable colonization in the stomach and intestinal environments, with the goal of developing intervention strategies to prevent or eradicate gastrointestinal PA colonization in hospitalized patients. The project utilizes bar-coded PA bacterial libraries and experimental methodologies to advance understanding of how PA establishes persistent carriage in the gastrointestinal tract despite antibiotic administration. Findings from this research are intended to inform evidence-based prevention strategies that may substantially reduce PA-related infections in hospitalized populations by targeting the gastrointestinal reservoir identified as a major source for subsequent systemic spread.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $431.8k | 2/19/26 |